Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.


An effective, well-accepted treatment will provide benefits to individuals, the health system, and society at large.


Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.


An effective, well-accepted treatment will provide benefits to individuals, the health system, and society at large.

Sleep apnea is a common, serious condition with significant morbidity, increased mortality, and substantial effects on daily functioning.